+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Analysis of risk factors for post-transplant lymphoproliferative disease in pediatric lung transplant recipients with cystic fibrosis



Analysis of risk factors for post-transplant lymphoproliferative disease in pediatric lung transplant recipients with cystic fibrosis



Pediatric Research 43(4 Part 2): 131A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030062510

Download citation: RISBibTeXText


Related references

Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort. Transplant Infectious Disease 20(1):, 2018

Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders in Cystic Fibrosis Lung Transplant Recipients: A Case Series. Transplantation Proceedings 51(1): 194-197, 2019

Risk factors that influence survival in kidney transplant recipients with post-transplant lymphoproliferative disease A multivariate analysis. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 178A, 2002

Post transplant lymphoproliferative disease in pediatric lung transplant recipients. Journal of Heart & Lung Transplantation 17(1): 65, 1998

Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring. Pediatric Transplantation 13(5): 606-610, 2009

Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest 123(3): 800-808, 2003

Risk factors for post-transplant lymphoproliferative disease in patients with cystic fibrosis. Clinical Transplantation 25(4): E430-E436, 2012

The use of objective case ascertainment to identify risk factors for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder in pediatric liver transplant recipients. Hepatology 36(4 Part 2): 662A, 2002

Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Pediatric Transplantation 5(5): 359-364, 2001

Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort. Pediatric Transplantation 11(1): 58-65, 2007

Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. American Journal of Transplantation 5(4 Pt 1): 775-780, 2005

Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients. Pediatric Hematology and Oncology 30(6): 520-531, 2013

Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Pediatric Transplantation 8(3): 243-248, 2004

Determination of Modifiable Risk Factors for Infection in the Early Post Lung Transplant Period for Pediatric Cystic Fibrosis Patients. Journal of Heart and Lung Transplantation 36(4): S276-S277, 2017

Post-transplant lymphoproliferative disorder in lung transplant recipients Factors other than the intensity of immunosuppressive drug therapy. Clinical & Investigative Medicine 18(4 Suppl. ): B139, 1995